But a positive sign in the nation's fight against RSV, the Covid vaccine maker,
Moderna,
says it's experimental RSV vaccine is significantly lowered
the risk of illness from the virus.
The company says it shot was effective in a large clinical trial,
studying Its effect in older adults
that stock is a 4%,
and moderna planning to apply for regulatory approval in the next few months.
The vaccine could become available by this time next year,
so hopefully that will help
come this next winter.